Acalabrutinib CAS 1420477-60-6

Acalabrutinib CAS 1420477-60-6

Paub meej
Acalabrutinib CAS 1420477-60-6, yog ib qho kev xaiv thib ob Bruton's tyrosine kinase (BTK) inhibitor uas irreversibly khi rau BTK protein, thaiv cov B-cell receptor signaling txoj kev, yog li inhibiting cov malignant BTK thiab ciaj sia taus.
Indications: Mantle cell lymphoma (MCL), chronic lymphocytic leukemia (CLL), me lymphocytic lymphoma (SLL), yav tas los tsis kho MCL
Kev faib tawm yam khoom
API
Share to
Xa kev nug
Hauj lwm lawm
Kev tsis

Zhejiang Hengkang Pharmaceutical Co., Ltd. yog ib qho ntawm feem txhim khu kev qha manufacturers thiab lwm tus neeg ntawm acalabrutinib cas 1420477-60-6 nyob rau hauv Suav teb, featured los ntawm cov khoom zoo thiab cov kev pab zoo. Thov so assured mus ua lag luam wholesale bulk acalabrutinib cas 1420477-60-6 ua nyob rau hauv Suav teb nov los ntawm peb lub hoobkas.

 

Khoom Taw Qhia

 

  • Acalabrutinib

Acalabrutinib CAS 1420477-60-6

1

Tshuaj npe

(S)-4-(8-amino-3-(1-but-2-ynoylpyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamide

Quanlity qauv

IH

Cov ntaub ntawv tswj hwm

N/A

Packing loj

25kg / nruas

Kev cia khoom

Tsis ntau tshaj 30 degree

 

Cim npe nrov: Acalabrutinib CAS 1420477-60-6, Tuam Tshoj acalabrutinib cas 1420477-60-6 manufacturers, lwm tus, Hoobkas

Xa kev nug
CDMOKev Pabcuam

Dedicated rau tshiab tshuaj R & D thiab zus tau tej cov APIs thiab intermediates.

Hu rau tam sim no!